Skip to content
Medical InsightsKoreaMedical Insights Korea

Opinion ·From Practice

The stone is out. So why am I being asked to come back?

A urologist on what the visit after stone surgery is actually for — the stent and its date, the fragments left behind on purpose, and a kidney that has to be seen to have gone down.

Signed opinion by a practising clinician. Written by Joon Chae Na, Specialist in Urology certified by Ministry of Health and Welfare, Republic of Korea, Clinic Director at Goldman Urology Clinic, Jamsil. Edited and translated by Medical Insights Korea.

In short

Removing a urinary stone does not finish the treatment, because three questions are still open: when the ureteral stent comes out, which is set against encrustation rather than comfort — in a European multicentre study, clinically significant encrustation in patients stented for stones rose from 8 percent before four months to nearly 17 percent after; whether fragments remain, which are neither a failed operation nor nothing, since fragments of 4 mm or less pass spontaneously only about a third of the time and any residual fragment raises the risk of repeat surgery; and whether a kidney that swelled behind the obstruction has returned to normal, which pain cannot report because obstruction is often silent — so the treatment ends when the kidney is confirmed to have recovered, not when the stone comes out.

Key takeaways

  • The object of stone treatment is the kidney rather than the stone, so it finishes when the kidney has been confirmed to have recovered.
  • The stent left in the ureter holds the drainage route open while the lining is swollen from breaking up and retrieving the stone.
  • Stent symptoms are expected rather than a sign something has gone wrong: in the study validating the stent symptom questionnaire, 78 percent of patients reported bothersome urinary symptoms and more than 80 percent had stent-related pain affecting daily activity.
  • The removal date is not a comfort question. In a European multicentre series of stents indwelling more than two months, clinically significant encrustation among stone patients rose from 8 percent before four months to nearly 17 percent after.
  • A fragment left behind deliberately is not a failed operation, but it is not harmless either: a systematic review of 52 studies found fragments of 4 mm or less pass on their own about a third of the time.
  • In 802 renal units followed a median of 4.2 years after ureteroscopy, 20 percent needed repeat surgery, and in non-obese patients a residual fragment of any size raised that risk.
  • Obstruction can be silent, so the absence of pain is not evidence the kidney is clear.
  • Fever with flank pain is the one that cannot wait. In obstructive urosepsis from ureteral stones, patients not decompressed had 19.2 percent mortality against 8.82 percent, and decompression delayed two days or more raised in-hospital mortality.

On the day the stone is out and the discharge instructions are handed over, most patients take it that the treatment has finished. The pain that had them holding their side for days has gone and passing urine is comfortable again, so it is a reasonable thing to think.

There is still something left to look at. When the tube placed in the ureter should come out, whether any fragments remain inside the kidney, and whether a kidney that had swollen behind the blockage has gone back to its ordinary size — these are checked in turn. If the object of stone treatment were the stone, the operation would be the end of it. The object is the kidney. So treatment finishes not at the moment the stone leaves the body but at the point the kidney is confirmed to have recovered.

The tube in the ureter, and why its date is not negotiable

The stent left in the ureter after the procedure is a temporary guarantee that urine has a way through. Breaking a stone up and retrieving it can leave the lining of the ureter swollen, and a narrowed passage sends urine back up towards the kidney. A fine tube holds the route open until the swelling has settled and enough fragments have passed, and it comes out once that has been confirmed.

While it is in, urine may feel urgent more often and the flank may feel heavy. That is the tube itself causing irritation, and it is closer to an expected change than a sign that something has gone wrong. In the study that validated the stent symptom questionnaire, 78 percent of patients reported bothersome urinary symptoms and more than 80 percent had stent-related pain interfering with daily activities.

This is the first place people go wrong. Because it is uncomfortable, some try to bring the removal forward on their own, and others let the date slide. Neither is free: pulling it early risks the flow closing off again before the ureter has settled, and leaving it late lets deposits build on the tube.

A fragment left behind is not a failed operation

The second thing people misread is being told that some stone remains, and hearing it as failure. When a stone is large, or spread through several branches of the kidney, it is sometimes not possible to take all of it in one sitting. Forcing an instrument at a fragment lodged deep can put a strain on the surrounding renal tissue, so rather than insisting on finishing in one go it is safer to protect kidney function and come at it over more than one occasion.

Where a stone has blocked the ureter and the kidney has swollen — hydronephrosis — opening the blocked passage and bringing the pressure inside the kidney down comes first. When to deal with what remains is decided from the size and position of the fragment together with how far the kidney has recovered. How many procedures it took is a poorer measure of how things have gone than how much of the kidney was preserved.

None of which means a fragment does not matter. A systematic review of 52 studies found that fragments of 4 mm or less — the ones usually called clinically insignificant — pass on their own about a third of the time, and that complications and re-intervention in the rest are not negligible. In a single-centre series of 802 renal units followed for a median of 4.2 years after ureteroscopy, 20 percent came back to theatre, and in non-obese patients a residual fragment of any size raised that risk. A fragment left on purpose is a decision with a review date attached. The date is the point.

No pain is not the same as nothing wrong

The third misreading is to treat the absence of pain as the situation having resolved. Stones recur often, and a stone that has grown back and is blocking the urinary passage frequently gives no particular sensation at first. Relying on pain as the signal lengthens the period during which pressure sits on the kidney, and over that period kidney function can fall away by degrees. It is the same reason that being told at a checkup that a kidney looks swollen is not worth postponing because nothing hurts.

The other direction matters too. Flank or back pain that keeps returning, or blood appearing in the urine, is worth having looked at. Pain arriving with a fever is the one that cannot wait, because it suggests infection has set in behind an obstruction. In a systematic review of obstructive urosepsis from ureteral stones, patients who were not decompressed had 19.2 percent mortality against 8.82 percent in those who were, and decompression delayed by two days or more raised in-hospital mortality.

What to settle before you leave

Go back to the day of discharge. What is worth taking away is not only the medication and the list of precautions but the next set of dates.

  1. When the ureteral stent is due to come out, and who is arranging it.
  2. When the remaining fragments and the swollen kidney will be looked at again.
  3. At what interval recurrence will be checked from then on.
  4. Which changes mean coming in earlier rather than waiting: flank pain returning, blood in the urine, and above all a fever.

Because stones come back in people who have had one, seeing a treatment through often has the effect of making the next procedure a smaller one. Taking the stone out does not take long. What state the kidney is left in is settled over the months that follow.

Sources

  1. Jung HD, Lee JY, Kang DH, Ko K, Koh DH, Kwon O, Koo KC, Kim KT, et al.

    Korean Society of Endourology and Robotics (KSER) recommendation on the diagnosis, treatment, and prevention of urolithiasis
  2. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ

    Indwelling ureteral stents: evaluation of symptoms, quality of life and utility
  3. Legrand F, Saussez T, Ruffion A, Celia A, Djouhri F, Musi G, Kalakech S, Desriac I, et al.

    Double loop ureteral stent encrustation according to indwelling time: results of a European multicentric study
  4. Quarà A, Jannello LM, Bravo-Balado A, Moretto S, Zorzi F, Gradilone U, Werth H, Corrales M, et al.

    The impact of clinically insignificant residual fragments following endourological management of urolithiasis: a systematic review of complications and re-intervention rates
  5. Iremashvili V, Li S, Penniston KL, Best SL, Hedican SP, Nakada SY

    Role of residual fragments on the risk of repeat surgery after flexible ureteroscopy and laser lithotripsy: single center study
  6. Benea A, Porav-Hodade D, Turaiche M, Rosca O, Lighezan DF, Rachieru C, Stanga L, Ilie AC, et al.

    Time to decompression in obstructive urosepsis from ureteral calculi: thresholds, initial diversion, and early biomarkers: a systematic review
  7. Asher GN, Viprakasit DP, Aymes SE, Lusk JB, Ross S, Baker C, Rains C, Wright ST, et al.

    Prevention of recurrent nephrolithiasis in adults and children: a systematic review